Top

Supportive Care in Cancer

Published in:

01-04-2024 | Fatigue | Review

The association between the gut microbiome and fatigue in individuals living with cancer: a systematic review

Authors: Julia Slack, Hye In Noh, Leila Ledbetter, Tara A. Albrecht

Published in: Supportive Care in Cancer | Issue 4/2024

Abstract

Purpose

Fatigue is the most distressing symptom for individuals with cancer. While numerous studies have investigated biological pathways that could underlie the mechanism of fatigue, the cause of fatigue remains unclear. This review aimed to investigate the association between gut microbial composition and fatigue in individuals with cancer.

Methods

Medline (PubMed), Embase (Elsevier), and CINAHL Complete (Ebscohost) were systemically searched on March 30, 2023, for articles investigating gut microbial composition (relative abundance, alpha diversity, and beta diversity) and fatigue in individuals with cancer; no limitations were placed on dates, participant age, nor cancer type/treatment.

Results

Microbial composition in the form of relative abundance was correlated with fatigue in six of the seven articles. A high relative abundance of g_Ruminoccocus was observed in individuals with low fatigue. An elevated relative abundance of g_Escherichia and f_Enterobacteriaceae was associated with high fatigue. However, other associations between fatigue and relative abundance composition, such as with g_Bifidobacterium and g_Faecalibacterium, had conflicting results. For alpha diversity and fatigue, the findings were contradictory; the association between beta diversity and fatigue was unclear due to conflicting results.

Conclusions

Pro-inflammatory bacteria, such as f_Enterobacteriaceae, were more commonly associated with higher fatigue scores, while anti-inflammatory or short-chain fatty acid producing bacteria, such as g_Ruminoccocus, were linked with lower fatigue scores in individuals with cancer. The relationship between alpha and beta diversity and fatigue was inconclusive. Further investigation is needed to clarify whether gut microbial changes play a correlative or causal role in the development of fatigue in individuals with cancer.

Available only for authorised users

Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage 61(1):167-189.e14. https://doi.org/10.1016/j.jpainsymman.2020.07.037CrossRefPubMed

Bower JE (2014) Cancer-related fatigue: mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597–609. https://doi.org/10.1038/nrclinonc.2014.127CrossRefPubMedPubMedCentral

Thong MSY, van Noorden CJF, Steindorf K, Arndt V (2020) Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol 21(2):17. https://doi.org/10.1007/s11864-020-0707-5CrossRefPubMedPubMedCentral

Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR (2019) Gut microbiome: profound implications for diet and disease. Nutrients 11(7):1613. https://doi.org/10.3390/nu11071613CrossRefPubMedPubMedCentral

Shreiner AB, Kao JY, Young VB (2015) The gut microbiome in health and in disease. Curr Opin Gastroenterol 31(1):69–75. https://doi.org/10.1097/MOG.0000000000000139CrossRefPubMedPubMedCentral

González-Mercado VJ, Pérez-Santiago J, Lyon D, Dilán-Pantojas I, Henderson W, McMillan S, Groer M, Kane B, Marrero S, Pedro E, Saligan LN (2020) The role of gut microbiome perturbation in fatigue induced by repeated stress from chemoradiotherapy: a proof of concept study. Advances in Medicine 2020:6375876. https://doi.org/10.1155/2020/6375876CrossRefPubMedPubMedCentral

Hajjar J, Mendoza T, Zhang L, Fu S, Piha-Paul SA, Hong DS, Janku F, Karp DD, Ballhausen A, Gong J, Zarifa A, Peterson CB, Meric-Bernstam F, Jenq R, Naing A (2021) Associations between the gut microbiome and fatigue in cancer patients. Scientific Reports 11(1), Article 1. https://doi.org/10.1038/s41598-021-84783-9

Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR (2021) Determining gut microbial dysbiosis: a review of applied indexes for assessment of intestinal microbiota imbalances. Appl Environ Microbiol 87(11):e00395-e421. https://doi.org/10.1128/AEM.00395-21CrossRefPubMedPubMedCentral

Eden J, Levit L, Berg A, Morton S (eds) (2011) Finding what works in health care: standards for systematic reviews. National Academies Press. https://doi.org/10.17226/13059CrossRef

10.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

11.

Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research. Retrieved May 14, 2023, from https://www.ihe.ca/advanced-search/standard-quality-assessment-criteria-for-evaluating-primary-research-papers-from-a-variety-of-fields

12.

McGuinness L, Higgins J (2020) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. 1–7. https://doi.org/10.1002/jrsm.1411

13.

Bai J, Bruner DW, Fedirko V, Beitler JJ, Zhou C, Gu J, Zhao H, Lin I-H, Chico CE, Higgins KA, Shin DM, Saba NF, Miller AH, Xiao C (2020) Gut microbiome associated with the psychoneurological symptom cluster in patients with head and neck cancers. Cancers 12(9):E2531. https://doi.org/10.3390/cancers12092531CrossRef

14.

González-Mercado VJ, Henderson WA, Sarkar A, Lim J, Saligan LN, Berk L, Dishaw L, McMillan S, Groer M, Sepehri F, Melkus GD (2021) Changes in gut microbiome associated with co-occurring symptoms development during chemo-radiation for rectal cancer: a proof of concept study. Biol Res Nurs 23(1):31–41. https://doi.org/10.1177/1099800420942830CrossRefPubMed

15.

González-Mercado VJ, Lim J, Yu G, Penedo F, Pedro E, Bernabe R, Tirado-Gómez M, Aouizerat B (2021) Co-occurrence of symptoms and gut microbiota composition before neoadjuvant chemotherapy and radiation therapy for rectal cancer: a proof of concept. Biol Res Nurs 23(3):513–523. https://doi.org/10.1177/1099800421991656CrossRefPubMedPubMedCentral

16.

Wang A, Ling Z, Yang Z, Kiela PR, Wang T, Wang C, Cao L, Geng F, Shen M, Ran X, Su Y, Cheng T, Wang J (2015) Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One 10(5):e0126312. https://doi.org/10.1371/journal.pone.0126312CrossRefPubMedPubMedCentral

17.

Paulsen JA, Ptacek TS, Carter SJ, Liu N, Kumar R, Hyndman L, Lefkowitz EJ, Morrow CD, Rogers LQ (2017) Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 25(5):1563–1570. https://doi.org/10.1007/s00520-016-3568-5CrossRef

18.

Wei H, Xie L, Zhao Y, He J, Zhu J, Li M, Sun Y (2023) Diverse gut microbiota pattern between mild and severe cancer-related fatigue in lung cancer patients treated with first-line chemotherapy: a pilot study. Thoracic Cancer 14(3):309–319. https://doi.org/10.1111/1759-7714.14765CrossRefPubMed

19.

Deleemans JM, Chleilat F, Reimer RA, Baydoun M, Piedalue K-A, Lowry DE, Henning J-W, Carlson LE (2022) The chemo-gut pilot study: associations between gut microbiota, gastrointestinal symptoms, and psychosocial health outcomes in a cross-sectional sample of young adult cancer survivors. Curr Oncol 29(5):2973–2994. https://doi.org/10.3390/curroncol29050243CrossRefPubMedPubMedCentral

20.

González-Mercado VJ, Lim J, Marrero S, Pedro E, Saligan LN (2021) Gut microbiota and fatigue in rectal cancer patients: a cross-sectional pilot study. Support Care Cancer 29(8):4615–4621. https://doi.org/10.1007/s00520-021-06013-2CrossRefPubMed

21.

Xiao C, Fedirko V, Beitler J, Bai J, Peng G, Zhou C, Gu J, Zhao H, Lin I-H, Chico CE, Jeon S, Knobf TM, Conneely KN, Higgins K, Shin DM, Saba N, Miller A, Bruner D (2021) The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 29(6):3173–3182. https://doi.org/10.1007/s00520-020-05820-3CrossRef

22.

Deleemans JM, Chleilat F, Reimer RA, Henning J-W, Baydoun M, Piedalue K-A, McLennan A, Carlson LE (2019) The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol. BMC Cancer 19:1243. https://doi.org/10.1186/s12885-019-6473-8CrossRefPubMedPubMedCentral

23.

Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15:73. https://doi.org/10.1186/s12967-017-1175-yCrossRefPubMedPubMedCentral

24.

Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, Viggiano A, Cibelli G, Chieffi S, Monda M, Messina G (2017) Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev 2017:3831972. https://doi.org/10.1155/2017/3831972CrossRefPubMedPubMedCentral

25.

Khazaei Y, Basi A, Fernandez ML, Foudazi H, Bagherzadeh R, Shidfar F (2023) The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial. BMC Complement Med Ther 23(1):339. https://doi.org/10.1186/s12906-023-04165-8CrossRefPubMedPubMedCentral

26.

Lee J-Y, Chu S-H, Jeon JY, Lee M-K, Park J-H, Lee D-C, Lee J-W, Kim N-K (2014) Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver 46(12):1126–1132. https://doi.org/10.1016/j.dld.2014.09.004CrossRef

27.

Vital M, Karch A, Pieper DH (2017) Colonic butyrate producing communities in humans: an overview using omics data. mSystems 2(6):e00130-17. https://doi.org/10.1128/mSystemsCrossRefPubMedPubMedCentral

28.

Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X (2018) Butyrate: a double-edged sword for health? Adv Nutr 9(1):21–29. https://doi.org/10.1093/advances/nmx009CrossRefPubMedPubMedCentral

29.

Lupo GFD, Rocchetti G, Lucini L, Lorusso L, Manara E, Bertelli M, Puglisi E, Capelli E (2021) Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME). Sci Rep 11:7043. https://doi.org/10.1038/s41598-021-86425-6CrossRefPubMedPubMedCentral

30.

Zhu L-B, Zhang Y-C, Huang H-H, Lin J (2021) Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr 10(5):84–92. https://doi.org/10.5409/wjcp.v10.i5.84CrossRefPubMedPubMedCentral

31.

Zeng M, Inohara N, Nuñez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10(1):18–26. https://doi.org/10.1038/mi.2016.75CrossRefPubMed

32.

Baldelli V, Scaldaferri F, Putignani L, Del Chierico F (2021) The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms 9(4):697. https://doi.org/10.3390/microorganisms9040697CrossRefPubMedPubMedCentral

33.

Bower JE, Lamkin DM (2013) Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun 30:S48–S57. https://doi.org/10.1016/j.bbi.2012.06.011CrossRefPubMed

34.

Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, Gibbons SM, Magis AT (2020) Health and disease markers correlate with gut microbiome composition across thousands of people. Nature Communications, 11(1), Article 1. https://doi.org/10.1038/s41467-020-18871-1

Title: The association between the gut microbiome and fatigue in individuals living with cancer: a systematic review
Authors: Julia Slack
Hye In Noh
Leila Ledbetter
Tara A. Albrecht
Publication date: 01-04-2024
Publisher: Springer Berlin Heidelberg
Keywords: Fatigue
Respiratory Microbiota
Published in: Supportive Care in Cancer / Issue 4/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-024-08468-5

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Image Credits

ASCO 2024 | Highlights of the Day: Breast cancer – metastatic/© 2024 American Society of Clinical Oncology, all rights reserved., ASCO 2024 | Highlights of the Day: Gynecologic Cancer/© 2024 American Society of Clinical Oncology, all rights reserved., ASCO 2024 | Highlights of the Day: Breast Cancer – local/regional/adjuvant/© 2024 American Society of Clinical Oncology, all rights reserved., Melanoma/© selvanegra / Getty Images / iStock, Antibody drug conjugated with cytotoxic payload/© Love Employee / Getty images / iStock

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2024

Keep calm and keep rowing: the psychophysical effects of dragon boat program in breast cancer survivors

Retrospective analysis of preoperative application of triple-modal pre-rehabilitation on postoperative recovery of colorectal cancer patients

The effectiveness of therapeutic artmaking on depression, anxiety, quality of life, and psychological distress in cancer patients on chemotherapy: a systematic review of the literature

Single nucleotide polymorphisms conferring susceptibility to leukemia and oral mucositis: a multi-center pilot study of patients prior to conditioning therapy for hematopoietic cell transplant

Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors